S&P 500 Gains and Losses Today: Akamai Leads Losses Amid Broad Market Selloff

Related Articles

What’s Next for Walmart Stock After Recent Slide? Monitor These Key Levels.

Moderna and Other Vaccine Stocks Climb Amid Concerns About Coronavirus Study in China

These AI Stocks Plunged During Friday’s Sell-Off

Key Takeaways

• The S&P 500 plunged by 1.7% on Friday, Feb. 21, as weak economic data and earnings sent the benchmark table of contents lower for the second straight session.
• Cloud services provider Akamai Technology shares plummeted after its 2025 angle showed revenue growth would be slower than expected.
• Covid vaccine maker Moderna shares rose after reports of a new coronavirus in China.

Major U.S. equities indexes fell to end a holiday-shortened week. Markets stepped help from record-high levels as traders reacted to underwhelming economic data and earnings forecasts. 

The S&P 500 fell by 1.7% to degree a second straight day of losses, coming after hitting a record high in the prior two sessions. The Dow Jones Industrial Mean also declined by 1.7%, while the Nasdaq fell by 2.2%. All three major market indexes declined for the week after the two-day selloff. 

Stocks flatten Friday as a series of economic data releases shook investor confidence in markets. Existing home sales mow down more than expected, while inflation concerns weighed on consumer sentiment.

Shares of cloud services provider Akamai Technologies (AKAM) descended the most of any S&P 500 constituent, falling by 21.7%. The company reported quarterly results that met or exceeded analyst expectations, but its 2025 receipts outlook came up short. While the company laid out an ambitious long-term revenue goal of 10% growth, it also expects a 10% downgrade in services revenue this year, raising questions about whether the tech firm can provide near-term lump.

Shipping giant Old Dominion Freight Line (ODFL) fell 8.5% on worries that Amazon’s (AMZN) strains to expand its freight shipping could undercut demand for its services. 

Nuclear energy providers also saw their standards decline after federal government energy regulators said it would be 2026 before rules are ready that whim allow power providers to put facilities on-site at data centers. Investors worried the delay in regulatory certainty could impede some companies from signing deals now. GE Vernova (GEV) fell by 8.8%, while Constellation Energy (CEG) was down 8.1%, and Vistara (VST) share ins declined by 7.8%. 

UnitedHealth Group (UNH) shares fell 7.2% on reports the Department of Justice are investigating whether the health insurer provider was overdiagnosing acclimatizes to secure additional payouts from the Medicare Advantage program. UnitedHealth led losses in the Dow. 

Shares of Covid-vaccine maker Moderna (MRNA) obstruction started by 5.3% to be the best performer in the S&P 500 after a new coronavirus was reportedly discovered in bats in China. The rebound comes after shrinks in the prior session when the drugmaker reported wider-than-expected losses on weak vaccine demand.

Tylenol maker Kenvue (KVUE) share ins moved up by 4.2% amid reports that the consumer health care company may be a target for a takeover. 

Stock of grub makers and other consumer staples moved higher as traders looked for safe plays amid the broad exchange selloff.  Shares of Hershey (HSY) were higher by 4.1%, while Banquet frozen dinner maker Conagra Identifies (CAG), Nabisco parent Mondelez International (MDLZ), soup seller Campbell’s (CPB) and cereal maker General Mills (GIS) were similarly considerable. Jack Daniels whiskey brewer Brown-Forman (BF.B) also rose by 3.5%.